Metraipolis › archive › dc_bcc3dc5846f3

HER2 inhibitor-based combination therapy for recurrent and metastatic salivary duct carcinoma in an elderly patient: a case report and literature review — Europe PMC PMID:41189937

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41189937
DOI
10.3389/fonc.2025.1590497
License (as archived)
solo-consultazione
Archived
2026-11-09T05:10:02.367Z
SHA-256 of the archived text
4fb62f82bf433212122aa3b709951e055b666bd2814c0768813d59c5e7ec21ff
Stable URL of this page
https://metraipolis.com/documento/dc_bcc3dc5846f3

How to cite

HER2 inhibitor-based combination therapy for recurrent and metastatic salivary duct carcinoma in an elderly patient: a case report and literature review — Europe PMC PMID:41189937 — Europe PMC (en), https://europepmc.org/article/MED/41189937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcc3dc5846f3 (Metraipolis archive dc_bcc3dc5846f3, sha256 4fb62f82bf433212122aa3b709951e055b666bd2814c0768813d59c5e7ec21ff)
BibTeX
@misc{dcbcc3dc5846f3,
  title = {HER2 inhibitor-based combination therapy for recurrent and metastatic salivary duct carcinoma in an elderly patient: a case report and literature review — Europe PMC PMID:41189937},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41189937},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcc3dc5846f3; sha256 4fb62f82bf433212122aa3b709951e055b666bd2814c0768813d59c5e7ec21ff},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41189937. Agents can read the archived copy with the MCP tool read_document.